Lithium perhydroantamanide complex (2:1): exposure of the peptide backbone in the analog of antamanide with antitoxic impotency.
The synthetic analog of antamanide in which all four phenylalanyl residues are hydrogenated to cyclohexylalanyl (Cha) residues, cyclic(Val-Pro-Pro-Ala-Cha-Cha-Pro-Pro-Cha-Cha), has a complete loss of antitoxic potency despite its ability to form ion complexes in the same manner as antamanide. The co...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
1985
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC390807/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3864151/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.82.21.7155 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|